Overall rank by patents
#34,037
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
A Plus Biotechnology Company Limited
USPTO PatentsView assignee record - 7 granted patents across 2 technology areas, active 2020–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
7
Total patents granted
2
CPC technology areas
8.4
Avg claims per patent
-
5-year filing velocity
The verdict
A holds 7 US patents across 2 technology areas, rank #34,037 of 50,000 tracked assignees.
- #34,037
- of 50,000 US assignees by volume
- Top 95%
- by Innovation Score (18.6/100)
- 8.4
- avg claims per patent
Portfolio overview
A Plus Biotechnology Company Limited has been granted 7 US utility patents between 2020 and 2025, placing A Plus Biotechnology Company Limited at rank #34,037 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 8.4 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, A Plus Biotechnology Company Limited is one of the more focused assignees in the PatentsView dataset. By volume, A sits between 5th Kind, Inc. (7 patents, rank #34,033) and A.celli Nonwovens S.p.a. (7 patents, rank #34,041) - the closest US assignees by grant volume. The composite Innovation Score of 18.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 7 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. A Plus Biotechnology Company Limited's 8.4 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 2 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark A Plus Biotechnology Company Limited against peers pursuing similar technology classes.
Who files at A's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- 5th Kind
5th Kind, Inc.
7 patents
- 6D Helmets
6D Helmets, LLC
7 patents
- 9143-8010 Quebec
9143-8010 QUEBEC INC.
7 patents
- A & B Packing Equ…
A & B Packing Equipment, Inc.
7 patents
- A&A International
A&A International, LLC
7 patents
- A Finkl & Sons
A. Finkl & Sons Co.
7 patents
- A C E Internation…
A.C.E. INTERNATIONAL COMPANY, INC.
7 patents
- A Celli Nonwovens…
A.CELLI NONWOVENS S.P.A.
7 patents
- A Plus Biotechnol… ◀
A Plus Biotechnology Company Limited
7 patents
What this shows A holds 7 patents at rank #34,037, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near A
By rank, the assignees closest to #34,037 in granted patent volume.
- 5th Kind, Inc. #34,033 · 7 patents
- 6D Helmets, Llc #34,034 · 7 patents
- 9143-8010 Quebec Inc. #34,035 · 7 patents
- A & B Packing Equipment, Inc. #34,036 · 7 patents
- A&A International, Llc #34,038 · 7 patents
- A. Finkl & Sons Co. #34,039 · 7 patents
- A.c.e. International Company, Inc. #34,040 · 7 patents
- A.celli Nonwovens S.p.a. #34,041 · 7 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in A's primary technology class.
- Covidien Lp 5,709 in class
- Koniniklijke Philips N.v. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag Gmbh International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- Depuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
A's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
19 Top 95% higher than 5% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 5 | 71.4% |
| 2022 | 1 | 14.3% |
| 2025 | 1 | 14.3% |
Which technologies does A Plus Biotechnology Company Limited patent most?
Top 2 of 2 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Simple
Frequently Asked Questions
How many patents does A Plus Biotechnology Company Limited hold?
A Plus Biotechnology Company Limited holds 7 US granted patents filed between 2020 and 2025, spanning 2 technology areas.
What is A Plus Biotechnology Company Limited's Innovation Score?
A Plus Biotechnology Company Limited has an Innovation Score of 18.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does A Plus Biotechnology Company Limited focus on?
A Plus Biotechnology Company Limited's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 5 patents. The company has filed patents in 2 CPC subclasses total.
Is A Plus Biotechnology Company Limited's patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for A Plus Biotechnology Company Limited.
What does claim depth mean for A Plus Biotechnology Company Limited's patents?
A Plus Biotechnology Company Limited's patents average 8.4 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the A Plus Biotechnology Company Limited patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
A's 7 grants land it in the top 95% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - A ranks #34,037 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.